Trinity Biotech unveils next-gen AI-powered CGM biosensor
July 24, 2025
Trinity Biotech (Nasdaq:TRIB) today announced its plans to add another continuous glucose monitor (CGM) system to the growing market.
Trinity Biotech (Nasdaq:TRIB) today announced its plans to add another continuous glucose monitor (CGM) system to the growing market.
Melanoma testing could one day be done at home with a skin patch and test strip with two lines, similar to COVID-19 home tests, according to University of Michigan researchers.
Researchers have harnessed the power of artificial intelligence to design a blueprint for building a vaccine that aims to teach the body’s immune system to fight cancer.
A new study from the University of Colorado Anschutz Medical Campus shows that free, open-source artificial intelligence (AI) tools can help doctors report medical scans just as well as more expensive commercial systems, without putting patient privacy at risk.
Thanks to a new technique, neurosurgeons at UMC Utrecht have been able to watch the blood flow in brain tissue live during surgery for the first time. Together with researchers from Eindhoven University of Technology, they have developed a method that allows them to detect the risk of a stroke during surgery sooner—and potentially prevent it. The technique could also be useful for other types of operations, such as kidney transplants.
A wearable technology developed by Technion Professor Hossam Haick and colleagues in China enables real-time, noninvasive tracking and optimized treatment for diabetic patients.
Precision cancer treatment on a larger scale is moving closer now that researchers have developed an AI platform to tailor protein components and arm the patient’s immune cells to fight cancer.
SimplyTest has launched SimplyTest Oral Health-IMPLANT, a new molecular assay designed to detect microbial species linked to peri-implant disease and implant failure. The test is the latest addition to the company’s growing SimplyTest Oral Health line, which also includes SimplyTest Oral Health-PERIO and others.
ALISO VIEJO, Calif., July 23, 2025 /PRNewswire/ — In a major milestone for chronic post-amputation pain treatment, the first commercial patient in the U.S. has been successfully implanted with the FDA-approved Altius® System – marking the beginning of the company’s mission to relieve pain and restore life for lower limb amputees.
New AI-Enabled Technology Aims to Personalize Fluid Management and Improve Outcomes Across Hospital Network